Gossamer Bio Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gossamer bio daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gossamer Bio Daily Today - Breaking & Trending Today

Monashee Investment Management LLC Reduces Stake in Gossamer Bio, Inc. (NASDAQ:GOSS)

Monashee Investment Management LLC lessened its stake in Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) by 34.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,459,854 shares of the company’s stock after selling 1,844,358 shares during the period. Gossamer Bio […] ....

United States , Faheem Hasnain , Piper Sandler , Goldman Sachs Group , Exchange Commission , York Mellon Corp , Gossamer Bio Inc , Monashee Investment Management , Citigroup Inc , Gossamer Bio , Free Report , Investment Management , New York Mellon Corp , Advocates Investment Management , Capital Management , Monaco Asset Management , Bio Stock Down , Get Free Report , Gossamer Bio Daily ,

Wedbush Begins Coverage on Gossamer Bio (NASDAQ:GOSS)

Wedbush Begins Coverage on Gossamer Bio (NASDAQ:GOSS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Faheem Hasnain , Monashee Investment Management , Gossamer Bio Inc , Securities Exchange Commission , Armistice Capital , Silverarc Capital Management , Vanguard Group Inc , Venture Management , Goldman Sachs Group , Gossamer Bio , Free Report , Marketbeat Ratings , Moderate Buy , Get Free Report , Exchange Commission , Capital Management , Investment Management , Tyrosine Kinase , Gossamer Bio Daily ,

Gossamer Bio (NASDAQ:GOSS) Receives "Outperform" Rating from Wedbush

Wedbush reaffirmed their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $6.00 price target on the stock. Wedbush also issued estimates for Gossamer Bio’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 earnings at ($0.17) EPS, Q3 2024 earnings […] ....

United States , Metlife Investment Management , Gossamer Bio Inc , Bridgefront Capital , Swiss National Bank , Jpmorgan Chase Co , Vanguard Group Inc , Gossamer Bio Company Profile , Goldman Sachs Group , Gossamer Bio , Free Report , Moderate Buy , Get Free Report , National Bank , Life Investment Management , Tyrosine Kinase , Gossamer Bio Daily ,

Gossamer Bio (NASDAQ:GOSS) PT Lowered to $8.00

Gossamer Bio (NASDAQ:GOSS) PT Lowered to $8.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Invesco Ltd , Goldman Sachs Group , Hong Kong Ltd , Gossamer Bio Inc , Gossamer Bio , Free Report , Moderate Buy , Get Free Report , State Teachers Retirement System , Street Group , Kong Ltd , Tyrosine Kinase , Gossamer Bio Daily ,

Gossamer Bio (NASDAQ:GOSS) Earns "Outperform" Rating from Wedbush

Wedbush restated their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a $6.00 price target on the stock. Wedbush also issued estimates for Gossamer Bio’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 earnings at ($0.17) […] ....

United States , Goldman Sachs Group , Silverarc Capital Management , Monashee Investment Management , Vanguard Group Inc , Venture Management , Armistice Capital , Gossamer Bio Company Profile , Gossamer Bio Inc , Gossamer Bio , Free Report , Moderate Buy , Get Free Report , Capital Management , Investment Management , Tyrosine Kinase , Gossamer Bio Daily ,